Total number of shares and voting rights in Zealand Pharma at November 30, 2023
01 December 2023 - 3:15AM
Total number of shares and voting rights in Zealand Pharma at
November 30, 2023
Company announcement – No. 41 / 2023
Total number of shares and voting rights in Zealand Pharma at
November 30, 2023
Copenhagen, Denmark, November 30, 2023 – Zealand Pharma
A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a
Copenhagen-based biotechnology company focused on the discovery and
development of innovative peptide-based medicines, in accordance
with section 32 of the Danish Capital Markets Act, announces the
total number of shares and voting rights in the Company at the end
of a calendar month during which there have been changes to its
share capital.
In Company announcement No. 39/2023 from November 16, 2023,
Zealand announced an increase in share capital relating to exercise
of employee warrants. Following these announcements, the table
below lists the total number of shares and voting rights in Zealand
up to and including November 30, 2023.
Date |
Number of shares(nominal value of DKK 1 each) |
Share capital(nominal value in DKK) |
Number of voting rights |
November 30, 2023 |
58,704,075 |
58,704,075 |
58,704,075 |
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology
company focused on the discovery and development of peptide-based
medicines. More than 10 drug candidates invented by Zealand have
advanced into clinical development, of which two have reached the
market and three candidates are in late-stage development. The
company has development partnerships with a number of blue-chip
pharma companies as well as commercial partnerships for its
marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen,
Denmark, with a presence in the U.S. For more information about
Zealand’s business and activities, please
visit www.zealandpharma.com.
Contact:
Adam Lange Investor Relations Officer Zealand Pharma Email:
akl@zealandpharma.com |
|
Anna Krassowska, PhD Vice President, Investor Relations &
Corporate Communications Zealand Pharma Email:
ank@zealandpharma.com |
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
From Sep 2024 to Oct 2024
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
From Oct 2023 to Oct 2024